Published in Br Med J on November 20, 1971
Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat (2002) 3.53
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci (1999) 2.36
Basal cortisol levels and cognitive deficits in human aging. J Neurosci (1994) 1.97
Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab (1997) 1.56
A theoretical examination of double-blind design. Can Med Assoc J (1967) 1.49
Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci (1999) 1.47
Vitamin C and the common cold. Can Med Assoc J (1971) 1.40
Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry (1990) 1.39
Evidence and belief. Can Med Assoc J (1977) 1.39
Megavitamin B-3 therapy for schizophrenia. Can Psychiatr Assoc J (1971) 1.11
Psychopathology in 15,909 pairs of veteran twins: evidence for a genetic factor in the pathogenesis of schizophrenia and its relative absence in psychoneurosis. Am J Psychiatry (1969) 1.10
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging (1996) 1.07
A comprehensive theory of schizophrenia. Int J Neuropsychiatry (1966) 1.05
Cloning and sequencing the Lactobacillus brevis gene encoding xylose isomerase. Gene (1992) 1.05
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Acta Psychiatr Scand Suppl (1990) 1.05
Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol (1997) 1.04
Late-onset bipolar disorder. Psychiatr Clin North Am (1988) 0.99
Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol (1995) 0.97
Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons. J Neurosci (1997) 0.95
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience (1986) 0.94
A five-year outcome of discharged chronic psychiatric patients. Can Psychiatr Assoc J (1972) 0.94
Apomorphine-induced penile tumescence in impotent patients--preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.94
Apomorphine: clinical studies on erectile impotence and yawning. Prog Neuropsychopharmacol Biol Psychiatry (1989) 0.94
Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. J Neurosci (1998) 0.93
Diazepam in high doses is effective in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.93
Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme. Environ Health Perspect (1995) 0.91
New concepts on tetanus immunization: naturally acquired immunity. J Hyg Epidemiol Microbiol Immunol (1975) 0.90
Circadian rhythm of plasma melatonin in endogenous depression. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.89
Alzheimer's disease may not be a spirochetosis. Neuroreport (1999) 0.89
Differential effect of unilateral and bilateral ECT. Am J Psychiatry (1970) 0.88
The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients. J Clin Pharmacol (1987) 0.87
Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci (1982) 0.87
Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biol Psychiatry (1994) 0.86
Effect of sleep deprivation on dopamine receptor function in normal subjects. J Neural Transm (1981) 0.86
Delayed death in imipramine poisoning. Br Med J (1967) 0.85
Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Trop Med Int Health (2008) 0.84
Protection against ultraviolet radiation. CMAJ (1992) 0.84
The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group. J Affect Disord (1997) 0.84
Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites. J Pharm Pharmacol (1985) 0.83
Direct-test PCR for detection of meningococcal DNA and its serogroup characterization: standardization and adaptation for use in a public health laboratory. J Med Microbiol (2003) 0.82
High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients. Psychopharmacology (Berl) (1983) 0.81
Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion. Brain Res Bull (1982) 0.81
Pellagra and schizophrenia. Psychosomatics (1970) 0.81
Outcome variables in presymptomatic individuals at higher risk of developing Alzheimer disease. Alzheimer Dis Assoc Disord (1996) 0.80
The Kleine-Levine syndrome--a variant? J Clin Psychiatry (1978) 0.80
Clinical and neuroendocrine studies with cholecystokinin peptides. Ann N Y Acad Sci (1985) 0.80
Baclofen in the treatment of tardive dyskinesia. Am J Psychiatry (1978) 0.80
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J Neurol Sci (1983) 0.80
Effect of LSD on Chromosomes. Can Med Assoc J (1968) 0.79
Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease. Brain Res Mol Brain Res (1993) 0.79
Effect of lithium on hypothalamic-pituitary dopaminergic function. Acta Psychiatr Scand (1978) 0.79
Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J Neurochem (1986) 0.79
CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging (1984) 0.79
Nutrition and schizophrenia. Can Fam Physician (1975) 0.78
Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study. Neuropsychopharmacology (1996) 0.78
Parkinsonism induced by high doses of diazepam. Biol Psychiatry (1985) 0.78
Levomepromazine receptor binding profile in human brain--implications for treatment-resistant schizophrenia. Acta Psychiatr Scand (1993) 0.78
Lack of cholinergic deficit in the neocortex in Pick's disease. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.78
A 10-year follow-up study of tardive dyskinesia. Acta Psychiatr Scand (1992) 0.78
Plasma melatonin--an index of brain aging in humans? Biol Psychiatry (1986) 0.78
The effect of Yohimbine, an alpha2 adrenergic receptor antagonist, on the growth hormone response to apomorphine in normal subjects. J Psychiatry Neurosci (1996) 0.77
Effect of some peptides on dopaminergic function in man. J Neural Transm Suppl (1990) 0.77
Effect of domperidone on apomorphine-induced growth hormone secretion in normal men. J Neural Transm (1982) 0.77
Comparative autoradiographic distribution of calcium channel antagonist binding sites for 1,4-dihydropyridine and phenylalkylamine in rat, guinea pig and human brain. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.77
Normalization of platelet [3H]imipramine binding in depressed patients during remission. Eur J Pharmacol (1982) 0.77
Cholecystokinin appears to have antipsychotic properties. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.77
Cholecystokinin and schizophrenia. Prog Brain Res (1986) 0.77
Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. Can J Neurol Sci (1986) 0.77
Effect of normal aging on the prolactin response to graded doses of sulpiride and to arginine. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.77
Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy. J Neurol Neurosurg Psychiatry (1976) 0.77
Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication. J Neural Transm Gen Sect (1991) 0.77
Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.77
Is levomepromazine a useful drug in treatment-resistant schizophrenia? Acta Psychiatr Scand (1992) 0.77
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. J Affect Disord (1994) 0.77
Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis. Biol Psychiatry (1983) 0.77
Buspirone: a potential atypical neuroleptic. Life Sci (1983) 0.77
beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects. Am J Psychiatry (1979) 0.77
Clonidine-induced growth hormone secretion in chronic schizophrenia. Acta Psychiatr Scand (1983) 0.77
Effect of imipramine on the circadian rhythm of plasma melatonin in unipolar depression. Chronobiol Int (1986) 0.76
Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease. Can J Physiol Pharmacol (1986) 0.76
Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum. Neuropharmacology (1982) 0.76
Cholecystokinin peptides, dopamine and schizophrenia--a review. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.76
Adverse effects of niacin in emergent psychosis. JAMA (1969) 0.76
A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression. Can J Psychiatry (1988) 0.76
The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline. Biol Psychiatry (1997) 0.76
Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Neuropharmacology (1983) 0.76
Nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients. Br J Psychiatry (1968) 0.76
Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. Life Sci (1985) 0.76
Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients. Life Sci (1985) 0.76
Treatment of Alzheimer's disease with sabeluzole: functional and structural correlates. Clin Neuropharmacol (1997) 0.76
Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects. Clin Invest Med (1988) 0.76
An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study. J Psychiatry Neurosci (1995) 0.76
Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.76
Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.76
Verapamil in the treatment of chronic schizophrenia. Psychopharmacol Bull (1987) 0.76
Characterization and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. Prog Clin Biol Res (1989) 0.76
Unique [3H]tryptamine binding sites in rat brain: distribution and pharmacology. Arch Int Pharmacodyn Ther (1984) 0.76